The weight loss trajectory of zovaglutide at 24 weeks appears comparable to semaglutide's trajectory at the same time point in STEP 1, but longer-duration Phase 3 data are needed to confirm this
Out of all the study participants, 39.6 percent were prescribed semaglutide for type 2 diabetes, 42.6 percent were prescribed liraglutide for type 2 diabetes, 11.1 percent were prescribed semaglutide for obesity, and 6.7 percent were prescribed liraglutide for obesity
Originally developed for type 2 diabetes management, Mounjaro has demonstrated significant weight loss benefits due to its unique ability to target both GLP-1 and GIP receptorsa dual-action approach that enhances its effectiveness beyond other weight loss medications
If you're seeing multiple providers, ensure they're all aware of your complete medication regimen to prevent conflicting advice or overlooked interactions
In the wake of that failed deal, both companies have announced places to trim costs
They will also assess your current medications to ensure there are no potential interactions or contraindications